{"id":242456,"date":"2025-11-20T18:48:51","date_gmt":"2025-11-20T18:48:51","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=242456"},"modified":"2025-11-20T18:48:51","modified_gmt":"2025-11-20T18:48:51","slug":"noi-medicamente-pentru-cancer-compensate-in-romania","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=242456","title":{"rendered":"Noi medicamente pentru cancer, compensate \u00een Rom\u00e2nia"},"content":{"rendered":"<p>\nMinisterul S\u0103n\u0103t\u0103\u0163ii extinde lista medicamentelor compensate \u015fi gratuite cu 11 molecule inovative destinate pacien\u0163ilor oncologici. Ofer\u0103 astfel acces la tratamente moderne pentru boli care p\u00e2n\u0103 acum nu aveau alternative rambursate \u00een Rom\u00e2nia.<\/p>\n<p>\nTebentafuspum devine primul tratament rambursat \u00een Rom\u00e2nia pentru melanomul uveal, o form\u0103 rar\u0103 \u015fi agresiv\u0103 de cancer pentru care nu a existat nicio alternativ\u0103 compensat\u0103 p\u00e2n\u0103 acum. Tratamentul devine accesibil tuturor pacien\u0163ilor prin sistemul public.<\/p>\n<p>\nSelpercatinibum aduce o diferen\u0163\u0103 major\u0103 \u00een dou\u0103 tipuri de boli dificile: cancerul pulmonar f\u0103r\u0103 celule mici (NSCLC) avansat, care reprezint\u0103 85-90% dintre cancerele pulmonare, \u015fi cancerul tiroidian medular avansat, o boal\u0103 rar\u0103 f\u0103r\u0103 nicio alternativ\u0103 terapeutic\u0103 p\u00e2n\u0103 acum. Evalu\u0103rile arat\u0103 c\u0103 aceast\u0103 terapie cre\u015fte supravie\u0163uirea \u015fi \u00eencetine\u015fte evolu\u0163ia bolii cu luni de zile.<\/p>\n<p>\nDurvalumabum deschide o cale nou\u0103 pentru pacien\u0163ii cu cancer de tract biliar, o patologie rar\u0103, diagnosticat\u0103 frecvent \u00een stadii avansate. Este un tratament de prim\u0103 linie, cu inten\u0163ie curativ\u0103, pentru care pacien\u0163ii rom\u00e2ni nu au avut niciodat\u0103 acces rambursat.<\/p>\n<p>\nLista include molecule moderne pentru cancerul de s\u00e2n avansat (Everolimus, Talazoparibum), cancerul colorectal metastazat (Regorafenibum), multiple forme de cancer de prostat\u0103 (Darolutamidum, Relugolixum, Enzalutamidum), leucemie limfocitar\u0103 cronic\u0103 (Zanubrutinibum) \u015fi mielom multiplu recidivat \u015fi refractar (Isatuximabum).<\/p>\n<p>\n\u201eFiecare lun\u0103 c\u00e2\u015ftigat\u0103, fiecare tratament nou \u015fi fiecare \u015fans\u0103 de a opri evolu\u0163ia bolii \u00eenseamn\u0103 timp \u015fi speran\u0163\u0103: timp pentru familie, timp pentru planuri, speran\u0163\u0103 pentru via\u0163\u0103&#8221;, a declarat ministrul S\u0103n\u0103t\u0103\u0163ii Alexandru Rogobete.<\/p>\n<p>\nToate aceste tratamente sunt destinate pacien\u0163ilor pentru care op\u0163iunile terapeutice erau extrem de limitate &#8211; unele pentru boli rare, altele pentru stadii \u00een care boala avansa rapid.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ministrul S\u0103n\u0103t\u0103\u0163ii Alexandru Rogobete anun\u0163\u0103 extinderea listei medicamentelor compensate \u015fi gratuite cu 11 molecule inovative pentru pacien\u0163ii oncologici, inclusiv primul tratament rambursat pentru melanomul uveal, o form\u0103 rar\u0103 \u015fi agresiv\u0103 de cancer.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[14610,323,55519],"class_list":["post-242456","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-cancer","tag-medicamente","tag-rogobete"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/242456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=242456"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/242456\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=242456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=242456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=242456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}